Codexis Announces Decision of Patrick Yang, PhD, Not to Seek Re-Election to Board of Directors
REDWOOD CITY, Calif., April 04, 2023 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading enzyme engineering company, today announced that Patrick Yang, PhD, will not seek re-election to the Codexis Board of Directors. Dr. Yang joined the Board in 2014 and served as the Chair of the Nominating and Corporate Governance Committee.
Related news for (CDXS)
- Today’s Top Performers: MoBot’s Market Review 08/14/25 10:00 AM
- Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA
- Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting
- Codexis Announces Byron Dorgan to Retire from Board of Directors
- 24/7 Market News Snapshot 09 April, 2025 – Codexis, Inc. (NASDAQ:CDXS)